Madrigal is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a liver disease with high unmet medical need. Madrigal’s medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed THR-β agonist designed to target key underlying causes of MASH. Rezdiffra is the first and only medication approved by both the FDA and European Commission for the treatment of MASH with moderate to advanced fibrosis (F2 to F3). An ongoing Phase 3 outcomes trial is evaluating Rezdiffra for the treatment of compensated MASH cirrhosis (F4c). The Clinical Practice Liaison (CPL) plays a vital field-based role within Madrigal’s Medical Affairs team, focused on improving the standard of care for patients with Metabolic Dysfunction-Associated Steatohepatitis (MASH/NASH/MASLD). The CPL will proactively engage healthcare professionals (HCPs) to provide guideline-based, non-promotional disease education on the identification, diagnosis, and management of MASH. This role centers on empowering clinical practices to adopt evidence-based care pathways, integrate non-invasive diagnostic tools, enhance risk stratification, and collaborate in multidisciplinary care models. The CPL will also serve as a bridge between the medical community and internal Madrigal teams, providing strategic insights that help shape broader corporate understanding and direction.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Education Level
Master's degree
Number of Employees
501-1,000 employees